Prostate Cancer VA Rating: DC 7528, Residuals, and Presumptive Rules

How the 100% rating and the six-month mandatory VA exam work

The Note under Diagnostic Code 7528 in 38 CFR 4.115b states:

“Note—Following the cessation of surgical, X-ray, antineoplastic chemotherapy or other therapeutic procedure, the rating of 100 percent shall continue with a mandatory VA examination at the expiration of six months. Any change in evaluation based upon that or any subsequent examination shall be subject to the provisions of § 3.105(e) of this chapter. If there has been no local reoccurrence or metastasis, rate on residuals as voiding dysfunction or renal dysfunction, whichever is predominant.”

• Watchful waiting and active surveillance: Veterans with localized, low-grade prostate cancer often choose active surveillance—monitoring via serial PSA tests, MRI scans, and repeat biopsies without immediate surgery or radiation. Diagnostic Code 7528 does not address active surveillance or watchful waiting, so how a claim is rated during surveillance depends on the medical evidence.
• Definitive and ongoing treatment: Following radical prostatectomy, external beam radiation, brachytherapy, cryotherapy, chemotherapy, or hormone therapy, the six-month post-treatment period begins only when the therapeutic procedure ceases.
• Reduction notice protections under 38 CFR 3.105(e): The 100% evaluation does not drop automatically at six months. The VA must conduct the mandatory exam, and if it shows no recurrence or metastasis and residuals below 100%, issue a proposed reduction notice under 38 CFR 3.105(e) giving 60 days to submit evidence and 30 days to request a predetermination hearing under 38 CFR 3.105(i) (which continues 100% payments pending a final decision). Any final reduction takes effect on the last day of the month in which a 60-day period from the date of notice to the beneficiary of the final rating action expires.

Rating prostate cancer residuals under 38 CFR 4.115a

When the post-treatment exam confirms remission without local recurrence or metastasis, Diagnostic Code 7528 rates residuals under 38 CFR 4.115a as voiding dysfunction or renal dysfunction, whichever is predominant (assigning the category with the highest rating, while non-overlapping disabilities may be rated separately under 38 CFR 4.14):

Under the veteran-alone compensation schedule effective 2025-12-01, 10% pays $180.42 monthly, 20% pays $356.66, 30% pays $552.47, 40% pays $795.84, and 60% pays $1,435.02 monthly. GFR, eGFR, and creatinine-based approximations calculated by a clinician are accepted under 38 CFR 4.115a.

Presumptive service connection: Agent Orange and the PACT Act

Most veterans qualify through presumptive service connection, requiring only a prostate cancer diagnosis and qualifying military service.

Herbicide exposure (Agent Orange) under 38 CFR 3.307 and 3.309(e)

Under 38 CFR 3.309(e) and 38 CFR 3.307(a)(6), prostate cancer is a presumptive herbicide-exposure disease when manifest to 10% or more at any time after service. As listed on the VA Agent Orange exposure page and in 38 CFR 3.307(a)(6) and 38 U.S.C. 1116(d), presumptive exposure applies if you served in:

• Republic of Vietnam and offshore waters (38 CFR 3.307(a)(6)(i), (iii); January 9, 1962 – May 7, 1975): Service in Vietnam, on inland waterways, or on a vessel not more than 12 nautical miles seaward from the demarcation line of the waters of Vietnam and Cambodia.
• PACT Act herbicide locations (38 U.S.C. 1116(d)): Any U.S. or Royal Thai military base in Thailand (January 9, 1962 – June 30, 1976); Laos (December 1, 1965 – September 30, 1969); Cambodia at Mimot or Krek, Kampong Cham Province (April 16, 1969 – April 30, 1969); Guam or American Samoa or their territorial waters (January 9, 1962 – July 31, 1980); or Johnston Atoll or a ship calling there (January 1, 1972 – September 30, 1977).
• Korean DMZ and C-123 Aircraft: Service in or near the Korean DMZ between September 1, 1967, and August 31, 1971 (on VA.gov; 38 CFR 3.307(a)(6)(iv) lists April 1, 1968 – August 31, 1971); repeated flight, ground, or medical contact with Agent Orange-contaminated C-123 aircraft (38 CFR 3.307(a)(6)(v)); or transporting, testing, or storing Agent Orange.

PACT Act burn pit presumptions (reproductive cancers)

On the VA PACT Act benefits page and the VA presumptive cancers related to burn pit exposure page, “Reproductive cancer of any type”—explicitly including prostate cancer—is presumptive for Gulf War and post-9/11 veterans who served in:

• On or after August 2, 1990: Bahrain, Iraq, Kuwait, Oman, Qatar, Saudi Arabia, Somalia, the United Arab Emirates (UAE), or the airspace above these locations.
• On or after September 11, 2001: Afghanistan, Djibouti, Egypt, Jordan, Lebanon, Syria, Uzbekistan, Yemen, or the airspace above these locations.

Veterans without presumptive exposure service can establish direct service connection under 38 CFR 3.303 or under the one-year chronic disease presumption in 38 CFR 3.307(a)(3) and 38 CFR 3.309(a) for “Tumors, malignant” manifest to 10% or more within one year of discharge.

Secondary conditions linked to prostate cancer and treatment

Under 38 CFR 3.310(a), conditions proximately caused or aggravated by service-connected prostate cancer or its treatment may qualify for secondary service connection with a medical nexus opinion:

• Erectile Dysfunction (Diagnostic Code 7522) and SMC-K (38 CFR 3.350(a)): Radical prostatectomy, radiation, brachytherapy, and hormone therapy frequently cause erectile dysfunction. Under 38 CFR 4.115b, Diagnostic Code 7522 assigns 0% and Footnote 1 (plus the General Note to 38 CFR 4.115b) directs review for Special Monthly Compensation (SMC-K) under 38 CFR 3.350(a) for loss of use of a creative organ. Under 38 CFR 3.350(a)(1)(iii), loss of a creative organ from a post-service operation is not treated as elective when the operation was advised on sound medical judgment for a pathological condition, so it does not bar SMC-K.
• Radiation Proctitis, Scars, Depression, and Peripheral Neuropathy: Pelvic radiation may cause radiation proctitis or bowel incontinence (38 CFR 4.114); surgery may leave painful or unstable scars under Diagnostic Code 7804 (38 CFR 4.118); and cancer distress, chemotherapy, or hormone therapy may cause secondary depression, anxiety, osteoporosis, or neuropathy.

What to expect at the C&P exam and on the Prostate Cancer DBQ

During an initial claim or six-month post-treatment exam, the clinician completes the Male Reproductive Organ Conditions (Including Prostate Cancer) Disability Benefits Questionnaire (DBQ), found on the VA Public DBQs page. The examiner documents whether a neoplasm is active or in remission, watchful waiting versus treatment completion dates (surgery, radiation, brachytherapy, chemotherapy, or hormone therapy), biopsy date and results (and other diagnostic test results), daily absorbent material changes, appliance use, daytime voiding intervals, nighttime awakenings, obstructed voiding symptoms, erectile dysfunction and retrograde ejaculation, and whether any renal dysfunction is present (Item 2D, a Yes/No question that instructs the examiner to also complete the appropriate genitourinary questionnaire—the Kidney Conditions DBQ—if renal dysfunction exists).

How a prostate cancer rating combines with other VA ratings

While rated at 100% under Diagnostic Code 7528, a veteran with additional disabilities independently rated at 60% or more may qualify for statutory SMC-S under 38 CFR 3.350(i), in addition to SMC-K for secondary erectile dysfunction. When rated on residuals under 38 CFR 4.115a, your residual percentage combines with other ratings—such as kidney stones or mental health conditions—under 38 CFR 4.25. Model your combined evaluation with our VA combined rating calculator.

When to seek accredited help with your claim

If your claim was denied, if the VA proposed reducing your 100% rating under 38 CFR 3.105(e) without proper notice or exam, or if residual incontinence or SMC-K was overlooked, consider working with a VA-accredited representative:

• Veterans Service Organizations (VSOs): Accredited representatives from the DAV, VFW, and American Legion assist with claims, reduction responses, and predetermination hearings free of charge.
• VA-Accredited Claims Agents and Attorneys: Accredited professionals certified by the VA Office of General Counsel handle Supplemental Claims, Higher-Level Reviews, and Board appeals.

No representative can promise a specific rating outcome. Verify accreditation through the VA Office of General Counsel Accreditation Search.